Digital Health company, Global Kinetics has built the Personal KinetiGraph , a system for detecting and monitoring Parkinson’s disease (PD). With this invention, it has marked its entry in the Remote Physiologic Monitoring (RPM) space in the U.S. market. 

David Buche has been appointed as the Vice President Sales and Marketing, General Manager US RPM Business by Global Kinetics. He will be leading the launch of PKG in the US. His acclaimed experience of 25 years of executive leadership and technology commercialization experience in medical devices/biotech industries speaks of his merit. 

He has held eminent positions with both Reprise Biomedical and StemoniX. Buche held sales, marketing or general management positions with Synovis (now Baxter), Integra Lifesciences, Liventa Bioscience and The Ametus Group. He is excited to join the company and bring to the masses the PKG with its unparalleled clinical experience and CMS/private payor enabled RPM economics.